Basal Cell Carcinoma, Susceptibility To, 1; Bcc1

Description

Cutaneous basal cell carcinoma (BCC) is the most common cancer among people of European ancestry (Stacey et al., 2009). The primary environmental risk factor for BCC is sun exposure, but genetics also has a substantial role. Some of the sequence variants that confer susceptibility seem to operate through their association with fair-pigmentation traits common among Europeans, resulting in reduced protection from the damaging effects of ultraviolet (UV) radiation. Other sequence variants have no obvious role in pigmentation or UV susceptibility but instead seem to operate in the contexts of growth and differentiation of the basal layers of the skin (Stacey et al., 2008; Epstein, 2008; Gudbjartsson et al., 2008; Rafnar et al., 2009). See ASIP (OMIM ), TYR (OMIM ), and SHEP5 (OMIM ) for examples of basal cell carcinoma associated with fair skin or sensitivity to sun.Basal cell carcinoma occurs as a feature of multiple syndromes, including basal cell nevus syndrome (BCNS ), Bazex syndrome (OMIM ), Rombo syndrome (OMIM ), Brooke-Spiegler syndrome (OMIM ), Muir-Torre syndrome (OMIM ), and xeroderma pigmentosum (see {278700}).Abnormalities in the Hedgehog signaling pathway are found in basal cell carcinomas; see SHH (OMIM ) and SMOH (OMIM ). Genetic Heterogeneity of Susceptibility to Basal Cell CarcinomaSusceptibility to basal cell carcinoma is a genetically heterogeneous trait. The BCC1 locus maps to chromosome 1p36. Also see BCC2 (OMIM ) on 1q42; BCC3 (OMIM ) on 5p15; BCC4 (OMIM ) on 12q13; BCC5 (OMIM )on 9p21; and BCC6 (OMIM )on 7q32. Variation in the 3-prime untranslated region of TP53 (OMIM ) increases susceptibility to basal cell carcinoma (BCC7 ).Somatic mutation contributing to the formation of basal cell carcinoma has been identified in the RASA1 (OMIM ), PTCH1 (OMIM ), and PTCH2 (OMIM ) genes.

Clinical Features

Phenotypes and symptoms related to Basal Cell Carcinoma, Susceptibility To, 1; Bcc1

  • Neoplasm
  • Carcinoma
  • Nevus
  • Basal cell carcinoma
  • Generalized hypopigmentation

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
No data available about the known clinical features onset.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Sources and references

You can check the following sources for additional information.

OMIM Rare Disease Search Engine

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like ZTTK SYNDROME; ZTTKS HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO; FSGS4 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5 DESANTO-SHINAWI SYNDROME; DESSH AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE; ALS16 PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD